UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

First‐in‐Human Study of the Safety and Efficacy of TOL101 Induction to Prevent Kidney Transplant Rejection

American journal of transplantation, 2014-06, Vol.14 (6), p.1346-1355

2014

Volltextzugriff (PDF)

Treatment of renal allograft rejection with T10B9.1A31 or OKT3: final analysis of a phase II clinical trial

Transplantation, 1997-07, Vol.64 (2), p.274

1997

Volltextzugriff (PDF)

Initial Phase 2 Safety, Efficacy, and Pharmacokinetic Study of TOL-101 for Induction Therapy in Kidney Transplantation: Abstract# 1363

Transplantation, 2014-07, Vol.98, p.89

2014

Volltextzugriff (PDF)

Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure

Transplantation proceedings, 2001-02, Vol.33 (1-2), p.1659-1660

2001

Volltextzugriff (PDF)

Telychian (Llandovery, Silurian) conodonts from the LaPorte City Formation of eastern Iowa, USA (East-Central Iowa Basin) and their implications for global Telychian conodont biostratigraphic correlation

Palaeontologia electronica, 2017

2017

Volltextzugriff (PDF)

Induction immunotherapy in heart transplantation with T10B9.1A-31 : A phase I study

The Journal of heart and lung transplantation, 1997-09, Vol.16 (9), p.913-916

1997

Volltextzugriff (PDF)

First in Man Evaluation of the Safety and Potential Efficacy of TOL101 Induction to Prevent Kidney Transplant Rejection: 434

Transplantation, 2012-11, Vol.94 (10S), p.959

2012

Volltextzugriff (PDF)

First in Man Evaluation of the Safety and Potential Efficacy of TOL101 Induction to Prevent Kidney Transplant Rejection: 434

Transplantation, 2012-11, Vol.94 (10S), p.102

2012

Volltextzugriff (PDF)

TOL101- Anti-αβTCR Monoclonal Antibody Immune Monitoring During Initial Phase 2 Renal Transplant Trials: 435

Transplantation, 2012-11, Vol.94 (10S), p.1158

2012

Volltextzugriff (PDF)

Simultaneous kidney-pancreas transplantation in a patient with small lymphocytic lymphoma

Transplantation, 2003-02, Vol.75 (3), p.414-416

2003

Volltextzugriff (PDF)

T10B9 MONOCLONAL ANTIBODY: SHORT ACTING NON-STIMULATING MONOCLONAL ANTIBODY THT SPARES GAMMA DELTA T-CELLS AND TREATS AND PREVENTS CELLULAR REJECTION: 1954

Transplantation, 2008-07, Vol.86 (2S), p.643

2008

Volltextzugriff (PDF)

Cytomegalovirus hyperimmune globulin for CMV disease refractory to ganciclovir in renal transplantation

Transplantation proceedings, 1995-10, Vol.27 (5 Suppl 1), p.46-46

1995

Volltextzugriff (PDF)

RECENT DEVELOPMENTS IN ADMIRALTY AND MARITIME LAW

Tort trial & insurance practice law journal, 2012-09, Vol.48 (1), p.1-25

2012

Volltextzugriff (PDF)

T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection

American journal of kidney diseases, 1989-11, Vol.14 (5 Suppl 2), p.61

1989

Volltextzugriff (PDF)

Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure

American journal of kidney diseases, 2003-02, Vol.41 (2), p.464-470

2003

Volltextzugriff (PDF)

T10B9 action: The effect of anti-t-cell antibody mitogenicity and graft rejection on the first dose cytokine response

Transplantation proceedings, 1997-02, Vol.29 (1), p.315-316

1997

Volltextzugriff (PDF)

Treatment of acute cellular rejection with T10B9.1A-31 or OKT3 in renal allograft recipients

Transplantation, 1992-01, Vol.53 (1), p.80

1992

Volltextzugriff (PDF)

Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study

Transplantation, 2008-05, Vol.85 (9), p.1261-1269

2008

Volltextzugriff (PDF)

Enhancing agency and empowerment in agricultural development projects: A synthesis of mixed methods impact evaluations from the Gender, Agriculture, and Assets Project, Phase 2 (GAAP2)

Journal of rural studies, 2024-05, Vol.108, p.103295, Article 103295

2024

Volltextzugriff (PDF)

Safety and tolerability of neoral vs Sandimmune : 1-year data in primary renal allograft recipients

Transplantation proceedings, 1996-08, Vol.28 (4), p.2183-2186

1996

Volltextzugriff (PDF)

Treatment of Respiratory Syncytial Virus Pneumonia in a Lung Transplant Recipient: Case Report and Review of the Literature

Pharmacotherapy, 2004-07, Vol.24 (7), p.932-938

2004

Volltextzugriff (PDF)

IMMUNOSUPPRESSION IN RENAL-TRANSPLANTATION DOES NOT INCREASE THE INCIDENCE OF NATIVE RENAL-CANCER

International journal of oncology, 1993-06

1993

Volltextzugriff (PDF)

Comparison of T10B9.1A-31 and OKT3 in treating acute renal allograft rejection

Transplantation proceedings, 1993-02, Vol.25 (1), p.543-545

1993

Volltextzugriff (PDF)

Impact of Acute Rejection Episodes on Long‐Term Graft Survival Following Simultaneous Kidney‐Pancreas Transplantation

American journal of transplantation, 2003-04, Vol.3 (4), p.439-444

2003

Volltextzugriff (PDF)

T10B9 (MEDI‐500) mediated immunosuppression: studies on the mechanism of action

Clinical transplantation, 1996-12, Vol.10 (6pt2), p.607-613

1996

Volltextzugriff (PDF)

1 – 25 von 823

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(598)
Mit Volltextzugriff
(594)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

First‐in‐Human Study of the Safety and Efficacy of TOL101 Induction to Prevent Kidney Transplant Rejection

Treatment of renal allograft rejection with T10B9.1A31 or OKT3: final analysis of a phase II clinical trial

Initial Phase 2 Safety, Efficacy, and Pharmacokinetic Study of TOL-101 for Induction Therapy in Kidney Transplantation: Abstract# 1363

Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure

Telychian (Llandovery, Silurian) conodonts from the LaPorte City Formation of eastern Iowa, USA (East-Central Iowa Basin) and their implications for global Telychian conodont biostratigraphic correlation

Induction immunotherapy in heart transplantation with T10B9.1A-31 : A phase I study

First in Man Evaluation of the Safety and Potential Efficacy of TOL101 Induction to Prevent Kidney Transplant Rejection: 434

First in Man Evaluation of the Safety and Potential Efficacy of TOL101 Induction to Prevent Kidney Transplant Rejection: 434

TOL101- Anti-αβTCR Monoclonal Antibody Immune Monitoring During Initial Phase 2 Renal Transplant Trials: 435

Simultaneous kidney-pancreas transplantation in a patient with small lymphocytic lymphoma

T10B9 MONOCLONAL ANTIBODY: SHORT ACTING NON-STIMULATING MONOCLONAL ANTIBODY THT SPARES GAMMA DELTA T-CELLS AND TREATS AND PREVENTS CELLULAR REJECTION: 1954

Cytomegalovirus hyperimmune globulin for CMV disease refractory to ganciclovir in renal transplantation

RECENT DEVELOPMENTS IN ADMIRALTY AND MARITIME LAW

T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection

Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure

T10B9 action: The effect of anti-t-cell antibody mitogenicity and graft rejection on the first dose cytokine response

Treatment of acute cellular rejection with T10B9.1A-31 or OKT3 in renal allograft recipients

Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study

Enhancing agency and empowerment in agricultural development projects: A synthesis of mixed methods impact evaluations from the Gender, Agriculture, and Assets Project, Phase 2 (GAAP2)

Safety and tolerability of neoral vs Sandimmune : 1-year data in primary renal allograft recipients

Treatment of Respiratory Syncytial Virus Pneumonia in a Lung Transplant Recipient: Case Report and Review of the Literature

IMMUNOSUPPRESSION IN RENAL-TRANSPLANTATION DOES NOT INCREASE THE INCIDENCE OF NATIVE RENAL-CANCER

Comparison of T10B9.1A-31 and OKT3 in treating acute renal allograft rejection

Impact of Acute Rejection Episodes on Long‐Term Graft Survival Following Simultaneous Kidney‐Pancreas Transplantation

T10B9 (MEDI‐500) mediated immunosuppression: studies on the mechanism of action

Suchergebnisse filtern